James J. Kramer, Ph.D., has been named vice president of operations, U.S. Biologics, BioReliance Corp. In his new position, Dr. Kramer is the U.S. Biologic Services value stream leader for the company, with responsibility for program management, quality, GMP-cell banking, clearance services, molecular biology, cell biology microbiology, virology, in vivo studies, support services and facilities. He will have direct responsibility for U.S. Biologics service delivery, quality and performance, emp...